Matches in Wikidata for { <http://www.wikidata.org/entity/Q64123477> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q64123477 description "clinical trial" @default.
- Q64123477 description "ensayu clínicu" @default.
- Q64123477 description "klinisch onderzoek" @default.
- Q64123477 description "клінічне випробування" @default.
- Q64123477 name "Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone" @default.
- Q64123477 type Item @default.
- Q64123477 label "Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone" @default.
- Q64123477 prefLabel "Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone" @default.
- Q64123477 P1050 Q64123477-F925192E-42A0-4152-93A2-E33A47DEFA45 @default.
- Q64123477 P1132 Q64123477-27A2F2BF-43C3-4430-BC05-4C4339BACC68 @default.
- Q64123477 P1476 Q64123477-42E57A96-05CB-4704-8518-16E54361B7D4 @default.
- Q64123477 P17 Q64123477-26ECE3FB-DF92-4C49-828B-EB84E84A62DD @default.
- Q64123477 P17 Q64123477-41B9944C-7E40-45C5-A0FC-EED4CD4FBC3A @default.
- Q64123477 P17 Q64123477-7E04CA30-C678-456A-ABA1-F0082E714579 @default.
- Q64123477 P17 Q64123477-F7F07A87-A45A-4804-A6A0-07C7AC4123FF @default.
- Q64123477 P2899 Q64123477-879C2698-7CC4-489D-8206-10E5CED985A1 @default.
- Q64123477 P3098 Q64123477-1A96D5EE-6DD5-40CB-A333-3838ABF4C290 @default.
- Q64123477 P31 Q64123477-BD319FD4-D59C-49E3-862E-4E10CA716848 @default.
- Q64123477 P4844 Q64123477-B780C98B-A54F-4FDA-997E-0802E378DB11 @default.
- Q64123477 P580 Q64123477-E6B48F94-15F9-4B17-9A28-7036FAA5A8E2 @default.
- Q64123477 P582 Q64123477-29582083-57E5-49C7-990B-5B59001EAF64 @default.
- Q64123477 P6099 Q64123477-267D08E9-185D-4122-93EA-F0074FD84B08 @default.
- Q64123477 P8363 Q64123477-FF7AFA82-45DE-4C7C-8868-A37D57039FED @default.
- Q64123477 P1050 Q180614 @default.
- Q64123477 P1132 "+68" @default.
- Q64123477 P1476 "A Phase 1 Open-label Study of Safety and Tolerability of MEDI4736 in Subjects With Metastatic or Unresectable Melanoma in Combination With Dabrafenib and Trametinib or With Trametinib Alone" @default.
- Q64123477 P17 Q142 @default.
- Q64123477 P17 Q16 @default.
- Q64123477 P17 Q30 @default.
- Q64123477 P17 Q38 @default.
- Q64123477 P2899 "+18" @default.
- Q64123477 P3098 "NCT02027961" @default.
- Q64123477 P31 Q30612 @default.
- Q64123477 P4844 Q7833138 @default.
- Q64123477 P580 "2013-12-20T00:00:00Z" @default.
- Q64123477 P582 "2018-04-24T00:00:00Z" @default.
- Q64123477 P6099 Q5452194 @default.
- Q64123477 P8363 Q78089383 @default.